ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Nexpovio 20 mg, Filmtabletten - 20
69230004 Stemline Therapeutics Switzerland GmbH
Nexpovio 20 mg, Filmtabletten29.04.2025
  29.04.2025
Selinexor (L01XX66) 
WHO-DDD28.04.2030
20
07.16.40. 
A  
No 
  
PR  
k.A.PR
  
7680692300041Synthetika
  
Composition
selinexorum 20 mg, cellulosum microcristallinum, carmellosum natricum conexum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, natrii laurilsulfas, Überzug: talcum, poly(alcohol vinylicus), glyceroli monopalmitostearas, polysorbatum 80, E 171, macrogolum 3350, E 132, E 133, pro compresso obducto corresp. natrium max. 1.028 mg.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Selinexorum20 mg
 
Inactive agentsDoseadditional_information
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 132 color.
E 133 color.
E 171 color.
Glyceroli Monopalmitostearas  
Macrogol3350  
Magnesii Stearas  
Natrii Laurilsulfas  
Poly(Alcohol Vinylicus)  
Polysorbatum 80  
Povidonum K30  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum Überzug
Source
Data was imported : 07.05.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home